| Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization AJ Shattock, HC Johnson, SY Sim, A Carter, P Lambach, RCW Hutubessy, ... The Lancet 403 (10441), 2307-2316, 2024 | 106 | 2024 |
| Return On Investment From Immunization Against 10 Pathogens In 94 Low-And Middle-Income Countries, 2011–30: Study estimates return on investment from immunization programs … SY Sim, E Watts, D Constenla, L Brenzel, BN Patenaude Health Affairs 39 (8), 1343-1353, 2020 | 104 | 2020 |
| Modeling the impact of vaccination for the immunization Agenda 2030: Deaths averted due to vaccination against 14 pathogens in 194 countries from 2021 to 2030 A Carter, W Msemburi, SY Sim, KAM Gaythorpe, P Lambach, A Lindstrand, ... Vaccine 42, S28-S37, 2024 | 83 | 2024 |
| The Full Value of Vaccine Assessments (FVVA): A framework for assessing and communicating the value of vaccines for investment and introduction decision-making R Hutubessy, JA Lauer, B Giersing, SY Sim, M Jit, D Kaslow, S Botwright BMC medicine 21 (1), 229, 2023 | 53 | 2023 |
| Economic benefits of immunization for 10 pathogens in 94 low-and middle-income countries from 2011 to 2030 using cost-of-illness and value-of-statistical-life approaches E Watts, SY Sim, D Constenla, S Sriudomporn, L Brenzel, B Patenaude Value in Health 24 (1), 78-85, 2021 | 30 | 2021 |
| Costs of immunization programs for 10 vaccines in 94 low-and middle-income countries from 2011 to 2030 SY Sim, E Watts, D Constenla, S Huang, L Brenzel, BN Patenaude Value in Health 24 (1), 70-77, 2021 | 28 | 2021 |
| The cost and cost-effectiveness of novel tuberculosis vaccines in low-and middle-income countries: A modeling study A Portnoy, RA Clark, M Quaife, CK Weerasuriya, C Mukandavire, ... Plos Medicine 20 (1), e1004155, 2023 | 26 | 2023 |
| Cost of nine pediatric infectious illnesses in low-and middle-income countries: a systematic review of cost-of-illness studies G de Broucker, SY Sim, L Brenzel, M Gross, B Patenaude, DO Constenla Pharmacoeconomics 38 (10), 1071-1094, 2020 | 24 | 2020 |
| A scoping review of investment cases for vaccines and immunization programs SY Sim, M Jit, D Constenla, DH Peters, RCW Hutubessy Value in health 22 (8), 942-952, 2019 | 18 | 2019 |
| Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling study AM Hartner, X Li, S Echeverria-Londono, J Roth, K Abbas, M Auzenbergs, ... The Lancet Global Health 12 (4), e563-e571, 2024 | 8 | 2024 |
| Estimating the impact of vaccination campaigns on measles transmission in Somalia N Thakkar, AHA Abubakar, M Shube, MA Jama, M Derow, P Lambach, ... Vaccines 12 (3), 314, 2024 | 6 | 2024 |
| Financing And Funding Gap For 16 Vaccines Across 94 Low-And Middle-Income Countries, 2011–30: Study examines funding gaps for sixteen vaccines across low-and middle-income … S Sriudomporn, SY Sim, J Mak, L Brenzel, BN Patenaude Health Affairs 42 (1), 94-104, 2023 | 6 | 2023 |
| A practical guide to full value of vaccine assessments C Trotter, B Giersing, A Lindstrand, N Bar-Zeev, T Cernuschi, ... Vaccines 12 (2), 201, 2024 | 4 | 2024 |
| Achieving immunization agenda 2030 coverage targets for 14 pathogens: Projected product and immunization delivery costs for 194 Countries, 2021–2030 S Sriudomporn, E Watts, SY Sim, R Hutubessy, B Patenaude Vaccine: X 13, 100256, 2023 | 4 | 2023 |
| Lessons learned from COVID-19 modelling efforts for policy decision-making in lower-and middle-income countries CJ Owek, FH Guleid, J Maluni, J Jepkosgei, VO Were, SY Sim, ... BMJ Global Health 9 (11), e015247, 2024 | 2 | 2024 |
| The Potential Economic Value of a Zika Vaccine for a Woman of Childbearing Age SM Bartsch, L Asti, OJ Stokes-Cawley, SY Sim, ME Bottazzi, PJ Hotez, ... American journal of preventive medicine 58 (3), 370-377, 2020 | 1 | 2020 |
| Informing the development of transmission modelling guidance for global immunization decision-making: A qualitative needs assessment J Leask, M Christou-Ergos, I Abdi, F Mboussou, MM Sabahelzain, ... Vaccine 49, 126800, 2025 | | 2025 |
| The role of public–private partnerships in NCD prevention and control AM Trager, S Ethan, SY Sim, N Banatvala Noncommunicable Diseases: A Compendium 1, Chapter 56, https://doi.org/10 …, 2023 | | 2023 |
| COUNTRY-LED ASSESSMENT FOR PRIORITISATION ON IMMUNISATION-UNDERSTANDING COUNTRY PREFERENCES AND THE VALUE OF PREFERENCE STUDIES FOR RESEARCH AND DEVELOPMENT OF VACCINE PRODUCTS … G Caramori, M Hiligsmann, R Hutubessy, S Botwright, SY Sim, B Giersing VALUE IN HEALTH 23, S563-S564, 2020 | | 2020 |
| PIN125 Country-LED Assessment for Prioritisation on Immunisation-Understanding Country Preferences and the VALUE of Preference Studies for Research and Development of Vaccine … G Caramori, M Hiligsmann, R Hutubessy, S Botwright, SY Sim, B Giersing Value in Health 23, S564-S565, 2020 | | 2020 |